HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
WDR19
WD repeat domain 19
Chromosome 4 Β· 4p14
NCBI Gene: 57728Ensembl: ENSG00000157796.19HGNC: HGNC:18340UniProt: B4DGR6
44PubMed Papers
25Diseases
0Drugs
143Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
intraciliary retrograde transportsperm midpieceprotein bindingintraciliary anterograde transportcranioectodermal dysplasiaSenior-Loken syndromenephronophthisisasphyxiating thoracic dystrophy 5
✦AI Summary

WDR19 (WD repeat domain 19) is a ciliary protein essential for intraflagellar transport (IFT) complex A assembly and retrograde ciliary transport 1. As a component of IFT-A, WDR19 mediates GPCR entry into cilia and is critical for cilium function and assembly 1. The protein contains six WD repeats, a clathrin heavy-chain repeat, and three transmembrane domains, with conserved expression from C. elegans to humans 2. Biallelic WDR19 variants cause multiple ciliopathies including nephronophthisis-13, Senior-Loken syndrome-8, short-rib thoracic dysplasia-5, and cranioectodermal dysplasia-4 3. Notably, WDR19 mutations have emerged as an unexpected cause of retinal degeneration phenocopying Stargardt disease 456. WDR19-associated retinopathy presents heterogeneously with features including nyctalopia, cone-rod degeneration patterns, photoreceptor atrophy, and notably preserved foveal regions in some patients 56. While nephronophthisis typically develops later, patients with CEP290 or IQCB1 variants develop earlier retinopathy onset 7. Pancreatic involvement is rare in WDR19-related ciliopathies but has been documented 8. These findings underscore WDR19's pivotal role in photoreceptor and renal ciliary function, with significant implications for genetic diagnosis of inherited retinal and kidney diseases.

Sources cited
1
WDR19 is a component of IFT complex A required for retrograde ciliary transport and GPCR entry into cilia
PMID: 20889716
2
WDR19 encodes a WD-repeat protein with six WD repeats, clathrin heavy-chain repeat, and three transmembrane domains; located on chromosome 4p15-4p11
PMID: 12906858
3
WDR19 mutations cause nephronophthisis-related ciliopathies including the first reported case of Caroli disease due to WDR19/NPHP13 mutations
PMID: 23559409
4
WDR19 variants cause Stargardt disease as a novel association, expanding the allelism phenomenon in ciliopathies
PMID: 32055034
5
WDR19-Stargardt patients present with nyctalopia, widespread fundus flecks, and severe rod photoreceptor impairment with foveal preservation
PMID: 36833218
6
WDR19-mediated retinal degeneration shows heterogeneous presentation with Stargardt-like or retinitis pigmentosa phenotypes; thickened external limiting membrane common
PMID: 40183892
7
WDR19 variants associated with Senior-Loken syndrome; retinopathy occurs alongside nephronophthisis development
PMID: 36990420
8
WDR19-related ciliopathies can rarely present with pancreatic involvement including severe recurrent pancreatitis
PMID: 35362211
Disease Associationsβ“˜25
cranioectodermal dysplasiaOpen Targets
0.79Strong
Senior-Loken syndromeOpen Targets
0.78Strong
nephronophthisisOpen Targets
0.77Strong
asphyxiating thoracic dystrophy 5Open Targets
0.74Strong
Jeune syndromeOpen Targets
0.72Strong
Senior-Loken syndrome 8Open Targets
0.70Moderate
spermatogenic failure 72Open Targets
0.61Moderate
Retinal dystrophyOpen Targets
0.46Moderate
connective tissue diseaseOpen Targets
0.45Moderate
Beemer-Langer syndromeOpen Targets
0.42Moderate
short-rib thoracic dysplasia 9 with or without polydactylyOpen Targets
0.42Moderate
genetic disorderOpen Targets
0.38Weak
ciliopathyOpen Targets
0.38Weak
cone dystrophyOpen Targets
0.37Weak
Juvenile nephronophthisisOpen Targets
0.37Weak
short rib dysplasiaOpen Targets
0.37Weak
Increased total eosinophil countOpen Targets
0.35Weak
retinitis pigmentosaOpen Targets
0.31Weak
Leber congenital amaurosisOpen Targets
0.27Weak
Bardet-Biedl syndromeOpen Targets
0.14Weak
Cranioectodermal dysplasia 4UniProt
Nephronophthisis 13UniProt
Senior-Loken syndrome 8UniProt
Short-rib thoracic dysplasia 5 with or without polydactylyUniProt
Spermatogenic failure 72UniProt
Pathogenic Variants143
NM_025132.4(WDR19):c.2129T>C (p.Leu710Ser)Pathogenic
Cranioectodermal dysplasia 4|Senior-Loken syndrome 8|Asphyxiating thoracic dystrophy 5|Senior-Loken syndrome 8;Asphyxiating thoracic dystrophy 5|not provided|Connective tissue disorder|Renal dysplasia and retinal aplasia|WDR19-related disorder|Nephronophthisis 13
β˜…β˜…β˜†β˜†2026β†’ Residue 710
NM_025132.4(WDR19):c.817A>G (p.Asn273Asp)Pathogenic
Jeune thoracic dystrophy|Asphyxiating thoracic dystrophy 5;Senior-Loken syndrome 8|Asphyxiating thoracic dystrophy 5;Nephronophthisis 13;Spermatogenic failure 72;Cranioectodermal dysplasia 4;Senior-Loken syndrome 8|Ciliopathy
β˜…β˜…β˜†β˜†2026β†’ Residue 273
NM_025132.4(WDR19):c.1122_1123insT (p.Pro375fs)Pathogenic
Asphyxiating thoracic dystrophy 5;Senior-Loken syndrome 8|not provided|WDR19-related disorder|Asphyxiating thoracic dystrophy 5;Cranioectodermal dysplasia 4;Nephronophthisis 13;Spermatogenic failure 72;Senior-Loken syndrome 8
β˜…β˜…β˜†β˜†2026β†’ Residue 375
NM_025132.4(WDR19):c.2363+1G>APathogenic
not provided|Senior-Loken syndrome 8;Asphyxiating thoracic dystrophy 5|Senior-Loken syndrome 8;Asphyxiating thoracic dystrophy 5;Nephronophthisis 13;Cranioectodermal dysplasia 4;Spermatogenic failure 72|Senior-Loken syndrome 8
β˜…β˜…β˜†β˜†2026
NM_025132.4(WDR19):c.3533G>A (p.Arg1178Gln)Pathogenic
Senior-Loken syndrome 8|not provided|Asphyxiating thoracic dystrophy 5;Senior-Loken syndrome 8|Nephronophthisis 13;Senior-Loken syndrome 8|Cranioectodermal dysplasia|Leber congenital amaurosis|Cranioectodermal dysplasia 4|Nephronophthisis 13|Asphyxiating thoracic dystrophy 5;Nephronophthisis 13;Cranioectodermal dysplasia 4;Spermatogenic failure 72;Senior-Loken syndrome 8|WDR19-related disorder|Asphyxiating thoracic dystrophy 5;Nephronophthisis 13;Cranioectodermal dysplasia 4;Senior-Loken syndrome 8
β˜…β˜…β˜†β˜†2025β†’ Residue 1178
NM_025132.4(WDR19):c.275T>G (p.Leu92Ter)Pathogenic
Senior-Loken syndrome 8;Asphyxiating thoracic dystrophy 5|not provided|Retinal disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 92
NM_025132.4(WDR19):c.1982+2T>CPathogenic
Asphyxiating thoracic dystrophy 5;Senior-Loken syndrome 8|Spermatogenic failure 72;Asphyxiating thoracic dystrophy 5;Nephronophthisis 13;Cranioectodermal dysplasia 4;Senior-Loken syndrome 8|Nephronophthisis 13
β˜…β˜…β˜†β˜†2025
NM_025132.4(WDR19):c.781dup (p.Thr261fs)Pathogenic
Jeune thoracic dystrophy|Nephronophthisis 13;Senior-Loken syndrome 8|Asphyxiating thoracic dystrophy 5;Senior-Loken syndrome 8|not provided|Asphyxiating thoracic dystrophy 5|Asphyxiating thoracic dystrophy 5;Nephronophthisis 13;Spermatogenic failure 72;Cranioectodermal dysplasia 4;Senior-Loken syndrome 8|Asphyxiating thoracic dystrophy 5;Nephronophthisis 13;Cranioectodermal dysplasia 4;Senior-Loken syndrome 8|WDR19-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 261
NM_025132.4(WDR19):c.3319C>T (p.Gln1107Ter)Pathogenic
Senior-Loken syndrome 8;Asphyxiating thoracic dystrophy 5|Spermatogenic failure 72;Senior-Loken syndrome 8;Nephronophthisis 13;Asphyxiating thoracic dystrophy 5;Cranioectodermal dysplasia 4
β˜…β˜…β˜†β˜†2025β†’ Residue 1107
NM_025132.4(WDR19):c.2716del (p.Glu906fs)Pathogenic
Cranioectodermal dysplasia 4;Senior-Loken syndrome 8;Asphyxiating thoracic dystrophy 5;Spermatogenic failure 72;Nephronophthisis 13|not provided|Senior-Loken syndrome 8;Asphyxiating thoracic dystrophy 5
β˜…β˜…β˜†β˜†2025β†’ Residue 906
NM_025132.4(WDR19):c.3565+1G>APathogenic
Senior-Loken syndrome 8|Jeune thoracic dystrophy|not provided|Asphyxiating thoracic dystrophy 5;Senior-Loken syndrome 8|Nephronophthisis 13|Connective tissue disorder|Colon adenocarcinoma
β˜…β˜…β˜†β˜†2025
NM_025132.4(WDR19):c.14T>C (p.Phe5Ser)Pathogenic
not provided|Retinal dystrophy|Asphyxiating thoracic dystrophy 5;Senior-Loken syndrome 8|Senior-Loken syndrome 8|Spermatogenic failure 72;Asphyxiating thoracic dystrophy 5;Nephronophthisis 13;Cranioectodermal dysplasia 4;Senior-Loken syndrome 8
β˜…β˜…β˜†β˜†2025β†’ Residue 5
NM_025132.4(WDR19):c.2601_2602dup (p.Tyr868fs)Pathogenic
Asphyxiating thoracic dystrophy 5;Nephronophthisis 13;Cranioectodermal dysplasia 4;Senior-Loken syndrome 8|Asphyxiating thoracic dystrophy 5;Senior-Loken syndrome 8
β˜…β˜…β˜†β˜†2025β†’ Residue 868
NM_025132.4(WDR19):c.2485C>T (p.Arg829Ter)Pathogenic
Cone dystrophy|Asphyxiating thoracic dystrophy 5;Nephronophthisis 13;Spermatogenic failure 72;Cranioectodermal dysplasia 4;Senior-Loken syndrome 8|Asphyxiating thoracic dystrophy 5;Senior-Loken syndrome 8
β˜…β˜…β˜†β˜†2025β†’ Residue 829
NM_025132.4(WDR19):c.2138_2139del (p.Ile713fs)Pathogenic
Senior-Loken syndrome 8;Asphyxiating thoracic dystrophy 5|Senior-Loken syndrome 8;Spermatogenic failure 72;Nephronophthisis 13;Asphyxiating thoracic dystrophy 5;Cranioectodermal dysplasia 4
β˜…β˜…β˜†β˜†2025β†’ Residue 713
NM_025132.4(WDR19):c.1135-2A>GLikely pathogenic
Cranioectodermal dysplasia 4;Senior-Loken syndrome 8;Asphyxiating thoracic dystrophy 5;Spermatogenic failure 72;Nephronophthisis 13|Senior-Loken syndrome 8;Asphyxiating thoracic dystrophy 5
β˜…β˜…β˜†β˜†2025
NM_025132.4(WDR19):c.3112C>T (p.Arg1038Ter)Pathogenic
Senior-Loken syndrome 8|Asphyxiating thoracic dystrophy 5;Senior-Loken syndrome 8
β˜…β˜…β˜†β˜†2025β†’ Residue 1038
NM_025132.4(WDR19):c.441G>A (p.Trp147Ter)Pathogenic
Senior-Loken syndrome 8;Asphyxiating thoracic dystrophy 5|WDR19-related disorder|Nephronophthisis 13
β˜…β˜…β˜†β˜†2025β†’ Residue 147
NM_025132.4(WDR19):c.3184-2A>CPathogenic
Senior-Loken syndrome 8;Asphyxiating thoracic dystrophy 5|Renal dysplasia and retinal aplasia|not provided|Senior-Loken syndrome 8;Asphyxiating thoracic dystrophy 5;Nephronophthisis 13;Spermatogenic failure 72;Cranioectodermal dysplasia 4
β˜…β˜…β˜†β˜†2025
NM_025132.4(WDR19):c.641T>A (p.Leu214Ter)Pathogenic
Retinal dystrophy|Asphyxiating thoracic dystrophy 5;Senior-Loken syndrome 8|not provided|Cranioectodermal dysplasia 4|Asphyxiating thoracic dystrophy 5;Nephronophthisis 13;Senior-Loken syndrome 8;Cranioectodermal dysplasia 4;Spermatogenic failure 72
β˜…β˜…β˜†β˜†2025β†’ Residue 214
View on ClinVar β†—
Related Genes
RPGRIP1LProtein interaction100%DYNC2I1Protein interaction100%IFTAPProtein interaction100%IFT74Protein interaction100%BBS1Protein interaction94%DYNC2LI1Protein interaction94%
Tissue Expression6 tissues
Ovary
100%
Liver
44%
Lung
39%
Bone Marrow
34%
Heart
21%
Brain
16%
Gene Interaction Network
Click a node to explore
WDR19RPGRIP1LDYNC2I1IFTAPIFT74BBS1DYNC2LI1
PROTEIN STRUCTURE
Preparing viewer…
PDB8BBG Β· 3.50 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.83LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.71 [0.60–0.83]
RankingsWhere WDR19 stands among ~20K protein-coding genes
  • #9,675of 20,598
    Most Researched44
  • #532of 5,498
    Most Pathogenic Variants143 Β· top 10%
  • #7,126of 17,882
    Most Constrained (LOEUF)0.83
Genes detectedWDR19
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
PMID: 27336129
1.00
2
Diverse Genetic Landscape of Suspected Retinitis Pigmentosa in a Large Korean Cohort.
PMID: 33946315
Genes (Basel) Β· 2021
0.90
3
PMID: 24027799
0.80
4
The morbid genome of ciliopathies: an update.
PMID: 32055034
Genet Med Β· 2020
0.70
5
Stargardt-like Clinical Characteristics and Disease Course Associated with Variants in the
PMID: 36833218
Genes (Basel) Β· 2023
0.60